These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 25974283

  • 1. Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake?
    Russell-Jones D, Danne T, Hermansen K, Niswender K, Robertson K, Thalange N, Vasselli JR, Yildiz B, Häring HU.
    Diabetes Obes Metab; 2015 Oct; 17(10):919-27. PubMed ID: 25974283
    [Abstract] [Full Text] [Related]

  • 2. Does insulin detemir have a role in reducing risk of insulin-associated weight gain?
    Hermansen K, Davies M.
    Diabetes Obes Metab; 2007 May; 9(3):209-17. PubMed ID: 17391147
    [Abstract] [Full Text] [Related]

  • 3. Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes.
    Zachariah S, Sheldon B, Shojaee-Moradie F, Jackson NC, Backhouse K, Johnsen S, Jones RH, Umpleby AM, Russell-Jones DL.
    Diabetes Care; 2011 Jul; 34(7):1487-91. PubMed ID: 21593292
    [Abstract] [Full Text] [Related]

  • 4. Central effects of insulin detemir on feeding, body weight, and metabolism in rats.
    Vasselli JR, Pi-Sunyer FX, Wall DG, John CS, Chapman CD, Currie PJ.
    Am J Physiol Endocrinol Metab; 2017 Nov 01; 313(5):E613-E621. PubMed ID: 28720583
    [Abstract] [Full Text] [Related]

  • 5. Insulin Detemir Is Transported From Blood to Cerebrospinal Fluid and Has Prolonged Central Anorectic Action Relative to NPH Insulin.
    Begg DP, May AA, Mul JD, Liu M, D'Alessio DA, Seeley RJ, Woods SC.
    Diabetes; 2015 Jul 01; 64(7):2457-66. PubMed ID: 25667307
    [Abstract] [Full Text] [Related]

  • 6. Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes.
    Herring R, Knight R, Shojaee-Moradie F, Johnsen S, Umpleby AM, Jackson N, Jones R, Dijk DJ, Russell-Jones DL.
    Diabetes Obes Metab; 2015 Nov 01; 17(11):1100-3. PubMed ID: 26272173
    [Abstract] [Full Text] [Related]

  • 7. Euglycemic infusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects.
    Hallschmid M, Jauch-Chara K, Korn O, Mölle M, Rasch B, Born J, Schultes B, Kern W.
    Diabetes; 2010 Apr 01; 59(4):1101-7. PubMed ID: 20068139
    [Abstract] [Full Text] [Related]

  • 8. Long-acting insulin analog detemir displays reduced effects on adipocyte differentiation of human subcutaneous and visceral adipose stem cells.
    Cignarelli A, Perrini S, Nigro P, Ficarella R, Barbaro M, Peschechera A, Porro S, Natalicchio A, Laviola L, Puglisi F, Giorgino F.
    Nutr Metab Cardiovasc Dis; 2016 Apr 01; 26(4):333-44. PubMed ID: 26947594
    [Abstract] [Full Text] [Related]

  • 9. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes.
    Marre M, Pinget M, Gin H, Thivolet C, Hanaire H, Robert JJ, Fontaine P.
    Diabetes Metab; 2009 Dec 01; 35(6):469-75. PubMed ID: 19914118
    [Abstract] [Full Text] [Related]

  • 10. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C, Hernández Herrero C, Rivas Fernández M.
    Diabet Med; 2008 Aug 01; 25(8):916-23. PubMed ID: 18959604
    [Abstract] [Full Text] [Related]

  • 11. Insulin detemir: a new basal insulin analogue.
    Soran H, Younis N.
    Diabetes Obes Metab; 2006 Jan 01; 8(1):26-30. PubMed ID: 16367879
    [Abstract] [Full Text] [Related]

  • 12. Similar glucose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification.
    Malek R, Ajili F, Assaad-Khalil SH, Shinde A, Chen JW, Van den Berg E.
    Diabetes Metab; 2015 Jun 01; 41(3):223-30. PubMed ID: 25483023
    [Abstract] [Full Text] [Related]

  • 13. Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.
    Owens DR, Bolli GB.
    Diabetes Technol Ther; 2008 Oct 01; 10(5):333-49. PubMed ID: 18715209
    [Abstract] [Full Text] [Related]

  • 14. Is a failure to recognize an increase in food intake a key to understanding insulin-induced weight gain?
    Ryan M, Livingstone MB, Ducluzeau PH, Sallé A, Genaitay M, Ritz P.
    Diabetes Care; 2008 Mar 01; 31(3):448-50. PubMed ID: 18086874
    [Abstract] [Full Text] [Related]

  • 15. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
    Haak T, Tiengo A, Draeger E, Suntum M, Waldhäusl W.
    Diabetes Obes Metab; 2005 Jan 01; 7(1):56-64. PubMed ID: 15642076
    [Abstract] [Full Text] [Related]

  • 16. Safety and effectiveness of insulin detemir in combination with oral antidiabetic agents in an outpatient specialist setting: results of the Italian SOLVE™ observational study.
    Caputo S, Maran A, Mannino D, Morano S, Lastoria G, Nicoziani P.
    Minerva Endocrinol; 2015 Dec 01; 40(4):249-58. PubMed ID: 26551483
    [Abstract] [Full Text] [Related]

  • 17. Can we reduce hypoglycaemia with insulin detemir?
    Mathieu C.
    Int J Obes Relat Metab Disord; 2004 Sep 01; 28 Suppl 2():S35-40. PubMed ID: 15306836
    [Abstract] [Full Text] [Related]

  • 18. Insulin-associated weight gain in diabetes--causes, effects and coping strategies.
    Russell-Jones D, Khan R.
    Diabetes Obes Metab; 2007 Nov 01; 9(6):799-812. PubMed ID: 17924864
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Insulin detemir: improving the predictability of glycaemic control.
    Russell-Jones D.
    Int J Obes Relat Metab Disord; 2004 Sep 01; 28 Suppl 2():S29-34. PubMed ID: 15306835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.